Abstract
(Am J Obstet Gynecol. 2017;216(3):296.e1–296.e14) Preeclampsia and intrauterine growth restriction (IUGR) are both placental diseases and major causes of perinatal and maternal morbidity and mortality. The most commonly used risk predictor for both IUGR and preeclampsia is obstetric history, and women are more significantly at risk if the condition occurred early in pregnancy and was severe. Previous studies have shown aspirin and calcium can significantly reduce the incidence of preeclampsia, and results from trials for heparin and low-molecular-weight-heparin (LMWH) have yielded conflicting results. This multicenter randomized controlled trial aimed to assess the use of LMWH for the prevention of small for gestational age (SGA) infants and preeclampsia in women with a history of these conditions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
